Geller MA

No ORCID on file · 5 papers in corpus · active 2010-2026
2026
Clinical proteomics ·doi:10.1186/s12014-026-09610-7

BackgroundEarlier detection is strongly associated with increased survival for women with ovarian cancer. Unfortunately, current screening strategies, employing serial serum or ultrasound assessments, lack adequate sensitivity and specifici…

2018
JCI insight ·doi:10.1172/jci.insight.96219

NK cell-based immunotherapies have been gaining traction in the clinic for treatment of cancer. IL-15 is currently being used in number of clinical trials to improve NK cell expansion and function. The objective of this study is to evaluate…

2013
Journal of genetic counseling ·doi:10.1007/s10897-013-9598-y

Little is known about genetic service utilization and ovarian cancer. We identified the frequency and outcome of genetic counseling referral, predictors of referral, and referral uptake for ovarian cancer patients. Using pathology reports, …

2010
Journal of ovarian research ·doi:10.1186/1757-2215-3-21

BackgroundNew biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrenc…

2010
American Journal of Clinical Pathology ·doi:10.1309/ajcpgxk0fr4mhihb

Early detection of ovarian cancer is difficult owing to the lack of specific and sensitive tests available. Previously, we found expression of nectin 4 to be increased in ovarian cancer compared with normal ovaries. Reverse transcriptase-po…